Get the Stockscreener App
7.48
3.19%
0.23
Mainz Biomed N V Stock (MYNZ) Forecast
The Mainz Biomed N V (MYNZ) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.5053, representing a -53.14% decrease from the current price of $7.48. The highest analyst price target is $4.5615, and the lowest is $2.4491.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MYNZ Price Target
Average 2.2865
(-69.43% Downside)
Is Mainz Biomed N V (MYNZ) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 66.89 | Neutral |
| STOCH(9,6) | 77.10 | Neutral |
| STOCHRSI(14) | 98.22 | Sell |
| MACD(12,26) | 0.462 | Buy |
| ADX(14) | 33.86 | Buy |
| William %R | -22.94 | Neutral |
| CCI(14) | 105.70 | Buy |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.2342
Buy
|
6.4335
Buy
|
| MA20 |
5.4661
Buy
|
5.8879
Buy
|
| MA50 |
5.7015
Buy
|
6.2863
Buy
|
| MA100 |
8.0132
Sell
|
8.8328
Sell
|
| MA200 |
14.25
Sell
|
17.74
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, MYNZ could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 5 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on MYNZ, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 66.89 indicates that MYNZ is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 77.1 indicates that MYNZ is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 98.22 indicates that MYNZ is oversold. This suggests that MYNZ price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.86 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 105.7 indicates that MYNZ is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term MYNZ price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Mainz Biomed N V financial reports and earnings history, Mainz Biomed N V (MYNZ) stock could reach $17.64 by 2030, $23.45 by 2040 and $82.39 by 2050. See the projected annual prices until 2050 of the Mainz Biomed N V stock below:
- Mainz Biomed N V (MYNZ) is expected to reach an average price of $8.2541 in 2035, with a high prediction of $8.5629 and a low estimate of $8.3541. This indicates an $10.35% rise from the last recorded price of $7.48.
- Mainz Biomed N V (MYNZ) stock is projected to chart a bullish course in 2040, with an average price target of $23.06, representing an $208.28% surge from its current level. The forecast ranges from a conservative $23.06 to a sky-high $23.45.
- Our analysts predict Mainz Biomed N V (MYNZ) to jump 532.26% by 2045, soaring from $47.29 to an average price of $47.29, potentially reaching $46.80. While $47.29 is the low estimate, the potential upside is significant.
- Mainz Biomed N V (MYNZ) stock is expected to climb by 2050, reaching an average of $82.13, a $997.94% jump from its current level. However, a wide range of estimates exists, with high and low targets of $82.39 and $6.0254, respectively, highlighting the market's uncertainty.
Mainz Biomed N V Stock (MYNZ) Year by Year Forecast
Mainz Biomed N V Stock (MYNZ) Price Forecast for 2025
Mainz Biomed N V Stock (MYNZ) is expected to reach an average price of $2.5629 in 2025, with a high prediction of $5.1144 and a low estimate of $0.0115. This indicates an -65.74% fall from the last recorded price of $7.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $2.6515 | $2.4491 | $4.5615 | -64.55% |
| April, 2025 | $2.5786 | $1.299 | $3.259 | -65.53% |
| May, 2025 | $0.9183 | $0.0309 | $2.636 | -87.72% |
| June, 2025 | $1.178 | $0.2658 | $1.638 | -84.25% |
| July, 2025 | $2.6952 | $0.8955 | $3.8664 | -63.97% |
| August, 2025 | $1.7549 | $1.0608 | $3.4342 | -76.54% |
| September, 2025 | $1.4446 | $0.9423 | $2.6771 | -80.69% |
| October, 2025 | $1.9617 | $1.442 | $2.6143 | -73.77% |
| November, 2025 | $2.0014 | $0.8214 | $2.719 | -73.24% |
| December, 2025 | $0.1285 | $0.0115 | $2.2162 | -98.28% |
Mainz Biomed N V Stock (MYNZ) Price Forecast for 2026
The predicted value for Mainz Biomed N V (MYNZ) in 2026 is set at an average of $1.0549. Estimates vary from a peak of $2.0905 to a trough of $0.0193, indicating an -85.90% surge from the present price of $7.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.9282 | $0.4208 | $1.6534 | -87.59% |
| February, 2026 | $1.1479 | $0.7357 | $2.0905 | -84.65% |
| March, 2026 | $0.9276 | $0.6628 | $1.4053 | -87.60% |
| April, 2026 | $0.4847 | $0.4547 | $1.445 | -93.52% |
| May, 2026 | $0.0456 | $0.0279 | $0.7221 | -99.39% |
| June, 2026 | $0.2541 | $0.0193 | $1.4467 | -96.60% |
| July, 2026 | $0.5988 | $0.071 | $0.5415 | -92.00% |
| August, 2026 | $1.1491 | $0.1865 | $0.9991 | -84.64% |
| September, 2026 | $1.0319 | $1.0568 | $1.0542 | -86.20% |
| October, 2026 | $0.6472 | $0.7822 | $0.7297 | -91.35% |
| November, 2026 | $0.7375 | $0.72 | $0.6324 | -90.14% |
| December, 2026 | $0.3944 | $0.4708 | $0.4277 | -94.73% |
Mainz Biomed N V Stock (MYNZ) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Mainz Biomed N V (MYNZ) is $6.3871, with a high forecast of $12.76 and a low forecast of $0.0109. This indicates an -14.61% decrease from the last price of $7.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0657 | $0.1437 | $0.238 | -99.12% |
| February, 2027 | $0.0479 | $0.0109 | $0.214 | -99.36% |
| March, 2027 | $8.4203 | $0.016 | $8.39 | +12.57% |
| April, 2027 | $8.7609 | $8.8705 | $8.1406 | +17.12% |
| May, 2027 | $3.5185 | $4.2014 | $7.1961 | -52.96% |
| June, 2027 | $1.5673 | $1.757 | $12.76 | -79.05% |
| July, 2027 | $3.9779 | $2.4127 | $1.965 | -46.82% |
| August, 2027 | $1.2285 | $1.6485 | $1.8367 | -83.58% |
| September, 2027 | $2.8442 | $1.0836 | $1.0842 | -61.98% |
| October, 2027 | $2.9648 | $3.2994 | $2.8545 | -60.36% |
| November, 2027 | $5.3809 | $3.41 | $3.7054 | -28.06% |
| December, 2027 | $4.3912 | $4.7209 | $4.6209 | -41.29% |
Mainz Biomed N V Stock (MYNZ) Price Forecast for 2028
In 2028, Mainz Biomed N V (MYNZ) is projected to reach an average price of $3.5112, with a high projection of $4.7034 and a low estimate of $2.319. This indicates an -53.06% fall from the last price of $7.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.1518 | $3.9466 | $3.6115 | -44.49% |
| February, 2028 | $4.0824 | $4.0569 | $3.8824 | -45.42% |
| March, 2028 | $5.9382 | $4.2727 | $4.6182 | -20.61% |
| April, 2028 | $4.7388 | $4.9388 | $4.7034 | -36.65% |
| May, 2028 | $2.4925 | $3.0194 | $4.2239 | -66.68% |
| June, 2028 | $3.6351 | $3.1197 | $2.905 | -51.40% |
| July, 2028 | $3.3457 | $3.8657 | $3.3606 | -55.27% |
| August, 2028 | $2.8205 | $3.1715 | $3.0912 | -62.29% |
| September, 2028 | $2.6921 | $2.6669 | $2.4366 | -64.01% |
| October, 2028 | $2.3627 | $2.7527 | $2.4924 | -68.41% |
| November, 2028 | $3.0884 | $3.1178 | $4.1681 | -58.71% |
| December, 2028 | $2.029 | $2.319 | $2.6687 | -72.87% |
Mainz Biomed N V Stock (MYNZ) Price Forecast for 2029
The 2029 price forecast for Mainz Biomed N V Stock (MYNZ) is $2.1625 on average, with a high prediction of $3.3581 and a low estimate of $0.9669. This represents an -71.09% decrease from the previous price of $7.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.6948 | $2.7953 | $2.4745 | -63.97% |
| February, 2029 | $2.5154 | $2.5654 | $2.3003 | -66.37% |
| March, 2029 | $3.216 | $2.8806 | $2.7909 | -57.01% |
| April, 2029 | $2.3266 | $2.6666 | $2.8613 | -68.90% |
| May, 2029 | $2.8424 | $2.7369 | $2.5774 | -62.00% |
| June, 2029 | $2.593 | $2.603 | $2.9527 | -65.33% |
| July, 2029 | $3.0536 | $3.2436 | $3.3581 | -59.18% |
| August, 2029 | $2.6793 | $2.7493 | $3.0339 | -64.18% |
| September, 2029 | $2.3699 | $2.3899 | $2.4645 | -68.32% |
| October, 2029 | $1.8815 | $1.8847 | $2.2351 | -74.85% |
| November, 2029 | $1.2763 | $1.3263 | $1.7198 | -82.94% |
| December, 2029 | $0.9419 | $0.9669 | $1.1264 | -87.41% |
Mainz Biomed N V Stock (MYNZ) Price Forecast for 2030
Mainz Biomed N V Stock (MYNZ) is expected to reach an average price of $9.2036 in 2030, with a high forecast of $17.64 and a low forecast of $0.7671. This signifies an +23.04% surge from the last price of $7.48.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $17.78 | $0.7671 | $17.64 | +137.67% |
| February, 2030 | $16.96 | $17.95 | $17.19 | +126.72% |
| March, 2030 | $12.30 | $16.10 | $16.41 | +64.43% |
| April, 2030 | $9.7904 | $3.8136 | $9.4604 | +30.89% |
| May, 2030 | $10.40 | $10.63 | $9.6791 | +39.03% |
| June, 2030 | $9.40 | $9.87 | $9.7568 | +25.67% |
| July, 2030 | $10.25 | $8.9554 | $8.2986 | +37.01% |
| August, 2030 | $10.16 | $10.87 | $10.38 | +35.82% |
| September, 2030 | $10.76 | $10.76 | $10.37 | +43.86% |
| October, 2030 | $10.41 | $11.73 | $11.63 | +39.23% |
| November, 2030 | $10.37 | $10.67 | $10.41 | +38.64% |
| December, 2030 | $10.70 | $10.67 | $10.24 | +43.06% |
0.28%
3.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):